Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach

JACC: Cardiovascular Interventions

Volumn 4, Issue 3, 2011, Pages 327-335

  Burzotta, Francesco ^a,b   Trani, Carlo ^a   Todaro, Daniel ^a   Mariani, Luca ^a   Talarico, Giovanni Paolo ^a   Tommasino, Antonella ^a   Giammarinaro, Maura ^a   Niccoli, Giampaolo ^a   Porto, Italo ^a   Leone, Antonio Maria ^a   Mongiardo, Rocco ^a   Mazzari, Mario Attilio ^a   Schiavoni, Giovanni ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

bifurcated lesions; drug eluting stent(s); percutaneous coronary interventions

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; STENT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT FAILURE;

EID: 79953012372     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.12.005     Document Type: Article

References (17)

1. A. Colombo, J.W. Moses, and M.C. Morice Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions Circulation 109 2004 1244 1249 (Pubitemid 38372783)
2. Y. Louvard, M. Thomas, and V. Dzavik Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv 71 2008 175 183 (Pubitemid 351293761)
3. M. Pan, J. Surez de Lezo, and A. Medina Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents Am Heart J 153 2007 15.e1 15.e7
4. Y.B. Song, J.Y. Hahn, and S.H. Choi Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry J Am Coll Cardiol 55 2010 1743 1750
5. G.W. Stone, A. Rizvi, W. Newman SPIRIT IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
6. F. Burzotta, G.A. Sgueglia, and C. Trani Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry J Invasive Cardiol 21 2009 532 537
7. F. Burzotta, H.C. Gwon, and J.Y. Hahn Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting) Report of bench testing and first clinical Italian-Korean two-centre experience Catheter Cardiovasc Interv 70 2007 75 82 (Pubitemid 47035998)
8. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
9. R. Gradaus, K. Mathies, G. Breithardt, and D. Bocker Clinical assessment of a new real time 3D quantitative coronary angiography system: evaluation in stented vessel segments Catheter Cardiovasc Interv 68 2006 44 49 (Pubitemid 44024460)
10. D. Dvir, H. Marom, A. Assali, and R. Kornowski Bifurcation lesions in the coronary arteries: early experience with a novel 3-dimensional imaging and quantitative analysis before and after stenting EuroIntervention 3 2007 95 99
11. R. Collingwood, E. Bermudez, and T.A. Fischell Comparison between three-dimensional angiographic reconstruction and intravascular ultrasound imaging for the measurement of cross-sectional luminal dimensions in intermediate coronary lesions J Interv Cardiol 22 2009 277 281
12. T.K. Steigen, M. Maeng, R. Wiseth NORDIC PCI Study Group Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study Circulation 114 2006 1955 1961 (Pubitemid 44665390)
13. J.A. Ormiston, M.W. Webster, and S. El Jack Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies Catheter Cardiovasc Interv 67 2006 49 55 (Pubitemid 43062609)
14. P. Mortier, D. Van Loo, and M. De Beule Comparison of drug-eluting stent cell size using micro-CT: important data for bifurcation stent selection EuroIntervention 4 2008 391 396
15. J.J. Popma, L. Mauri, and C. O'Shaughnessy Frequency and clinical consequences associated with side branch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents Circ Cardiovasc Interv 2 2009 133 139
16. R. Applegate, J. Hermiller, and J. Williams Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial Catheter Cardiovasc Interv 76 2010 644 651
17. B.K. Koo, H.J. Kang, and T.J. Youn Physiologic assessment of jailed side branch lesions using fractional flow reserve J Am Coll Cardiol 46 2005 633 637